The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bockenstedt, L. K.
Right arrow Articles by Weiss, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bockenstedt, L. K.
Right arrow Articles by Weiss, A.

The Journal of Immunology, Vol 141, Issue 6 1904-1911, Copyright © 1988 by American Association of Immunologists


ARTICLES

The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor

LK Bockenstedt, MA Goldsmith, M Dustin, D Olive, TA Springer and A Weiss
Division of Rheumatology and Clinical Immunology, University of California, San Francisco.

The T cell Ag receptor (CD3/Ti) and the sheep E receptor (CD2) expressed on the surface of human T cells are both capable of initiating intracellular signals necessary for T cell activation. CD3/Ti interacts with Ag to initiate cellular immune responses. Although the exact function of CD2 is unknown, lymphocyte function- associated Ag 3 (LFA-3), a 55- to 70-kDa receptor expressed on a broad spectrum of hemopoietic and nonhemopoietic cells, has recently been shown to be its natural ligand. We show here that although purified multimeric LFA-3 is not capable of initiating transmembrane signaling events on its own, the combination of LFA-3 and the anti-CD2 mAb CD2.1 induces intracellular calcium increases, phosphatidylinositol second messenger generation and lymphokine secretion in the T cell leukemic line Jurkat. In order to study the signaling requirements of CD2, we compared the ability of CD2 mAb and LFA-3 to initiate activation signals in Jurkat and in three Jurkat-derived mutants. A CD3-CD2+ mutant failed to increase calcium or exhibit phosphatidylinositol hydrolysis to either the combination of agonist CD2 mAb 9-1 and 9.6 or LFA-3 and CD2.1. Reconstitution of the Ag receptor by transfection of the Ti-beta-chain restored the expression of the CD3/Ti complex and the ability to respond to either combination of CD2 ligands. However, no response to CD2 ligands was detected in a CD3+CD2+ mutant selected for signaling defects to CD3/Ti ligands. Complementation of the CD3/Ti signaling defect by cell fusion also restored competency to respond to CD2 agonists. These results demonstrate that LFA-3 under appropriate conditions can activate T cells via the CD2 complex and that this activation requires not only the cell surface expression of the CD3/Ti complex but also a functional Ag receptor pathway.


This article has been cited by other articles:


Home page
JCBHome page
Y. Kaizuka, A. D. Douglass, S. Vardhana, M. L. Dustin, and R. D. Vale
The coreceptor CD2 uses plasma membrane microdomains to transduce signals in T cells
J. Cell Biol., May 4, 2009; 185(3): 521 - 534.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Milstein, S.-Y. Tseng, T. Starr, J. Llodra, A. Nans, M. Liu, M. K. Wild, P. A. van der Merwe, D. L. Stokes, Y. Reisner, et al.
Nanoscale Increases in CD2-CD48-mediated Intermembrane Spacing Decrease Adhesion and Reorganize the Immunological Synapse
J. Biol. Chem., December 5, 2008; 283(49): 34414 - 34422.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. G. Agrawal, J. Marquet, J. Plumas, H. Rouard, M.-H. Delfau-Larue, P. Gaulard, L. Boumsell, F. Reyes, A. Bensussan, and J.-P. Farcet
Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue
Int. Immunol., April 1, 2001; 13(4): 441 - 450.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
P. Hollsberg
Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I
Microbiol. Mol. Biol. Rev., June 1, 1999; 63(2): 308 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Sunder-Plassmann and E. L. Reinherz
A p56lck-independent Pathway of CD2 Signaling Involves Jun Kinase
J. Biol. Chem., September 11, 1998; 273(37): 24249 - 24257.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. J. Kivens, S. W. Hunt III, J. L. Mobley, T. Zell, C. L. Dell, B. E. Bierer, and Y. Shimizu
Identification of a Proline-Rich Sequence in the CD2 Cytoplasmic Domain Critical for Regulation of Integrin-Mediated Adhesion and Activation of Phosphoinositide 3-Kinase
Mol. Cell. Biol., September 1, 1998; 18(9): 5291 - 5307.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. D. Gray, M. Hirokawa, K. Ohtsuka, and D. A. Horwitz
Generation of an Inhibitory Circuit Involving CD8+ T Cells, IL-2, and NK Cell-Derived TGF-{beta}: Contrasting Effects of Anti-CD2 and Anti-CD3
J. Immunol., March 1, 1998; 160(5): 2248 - 2254.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Dustin
Adhesive Bond Dynamics in Contacts between T Lymphocytes and Glass-supported Planar Bilayers Reconstituted with the Immunoglobulin-related Adhesion Molecule CD58
J. Biol. Chem., June 20, 1997; 272(25): 15782 - 15788.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. Webb, Y Shimizu, G. Van Seventer, S Shaw, and T. Gerrard
LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release
Science, September 14, 1990; 249(4974): 1295 - 1297.
[Abstract] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
M.H. Brown, E. Monostori, M. Gullberg, R. Zamoyska, G. Lang, D. Kioussis, and M.J. Crumpton
Structure-Function Relationships of the Human T Lymphocyte CD2 Antigen
Cold Spring Harb Symp Quant Biol, January 1, 1989; 54(0): 627 - 636.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.